Expanding HIV's Host Range: A Response

Editor’s note: Last November 30, we published an Opinion piece by Alexander Kohn, professor of virology at Tel Aviv University. In the article, Kohn questioned the wisdom of inserting the CD4 gene from HIV into cell lines, especially HeLa cells. Such research could, Kohn suggested, expand the host range of HIV In this response, Howard M Temin, of the McArdle Laboratory for Cancer Research, tries to lay Kohn’s concern to rest. We invite further comment. Alexander Kohn and the headl

Written byHoward Temin
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Alexander Kohn and the headline writer have changed the meaning of a term in their suggestion that the proposed work with HeLa cells would result in an expansion of HIV’s host range (“The Dangers of Expanding HIV’s Host Range,” November 30, 1987, p. 11). The work objected to would allow HIV to replicate in some modified HeLa cells. However, there is no evidence or even suggestion that such growth would result in a changed virus. Thus, the virus would not have an expanded host range in the usual sense of this term. The virus could merely grow on some additional laboratory cells. Culturing more T4-positive human cells would also provide additional cells for HIV growth. Stated in this way, it is clear that there is no safety problem with this experiment.

Two interesting questions are raised in the article. The first relates to the statement that “HIV mutates at least ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies